Henry Schein stock reflects raised 2026 guidance

Published on 10/03/2026 at 20:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock was last at USD 84.88 on October 2, 2026, while Q2 revenue reached USD 3.46 billion. Fiscal 2026 sales guidance rose to 4.5%-5.5%.

Isometrische 3D-Illustration der Lieferkette von Medizinprodukten von Produktion zu Klinik — Henry Schein US42548G1040 Wertschöpfungskette vom Hersteller über Lager bis zur Zahnarztpraxis isometrisch dargestellt, Illustration mit AI erstellt.

Henry Schein (ISIN US8064071025) was last at USD 84.88 on Nasdaq on October 2, 2026 at 4:00 p.m. ET, down 0.06 percent from the prior close. The main operating signal remains the company's raised fiscal 2026 outlook after second-quarter sales reached USD 3.46 billion.

Guidance rises after Q2 growth

According to The Globe and Mail on August 4, 2026, Henry Schein lifted fiscal 2026 sales growth guidance to 4.5%-5.5% from 3%-5%. Non-GAAP diluted EPS guidance also rose to USD 5.29-5.39 from USD 5.23-5.37.

The Q2 figures support that change. MarketBeat reported USD 1.27 in EPS against USD 1.24 consensus and USD 3.46 billion in revenue against USD 3.37 billion estimates. Revenue increased 6.7 percent year over year, giving investors a quantified comparison behind the guidance update.

Margin and cash flow add support

The same Q2 transcript showed non-GAAP operating margin of 7.21 percent, 25 basis points above the prior-year period, while GAAP operating margin was 4.94 percent. Operating cash flow reached USD 242 million in Q2 2026, according to the earnings-call material.

Henry Schein is also pursuing value-creation initiatives targeting more than USD 200 million in operating income improvements over several years. Management said the plan carries a USD 125 million operating-income run rate target by the end of 2026, creating a measurable execution test for the upgraded outlook.

Analyst target remains above price

MarketBeat cited a Moderate Buy consensus from 15 analysts and an average 12-month price target of USD 92.93. That target stands USD 8.05 above the October 2 price, while the stock's 52-week high is USD 92.18, making execution against the new guidance the central valuation question.

Stock remains below yearly high

Henry Schein was last at USD 84.88 on Nasdaq on October 2, 2026, with a session range of USD 83.45 to USD 85.31. Its market capitalization was USD 9.7 billion, and volume reached 1,131,677 shares.